Scalper1 News
Opko Health (OPK) agreed to buy lab services company Bio-Reference Laboratories (BRLI) for $1.47 billion in stock Thursday. Bio-Reference shareholders will get 2.75 shares of Opko stock for each share held. Based on Opko’s closing price of 19.12 Wednesday, the 2.75-for-1 deal valued Bio-Reference at 52.58 a share. Opko stock hit a record high of 19.20 Wednesday. Opko stock, however, was near 17.75, down 7% in morning trading on the stock market Scalper1 News
Scalper1 News